Cara Therapeutics

Cara Therapeutics Employee Directory

Biotechnology ResearchConnecticut, United States51-200 Employees

Cara Therapeutics is a development-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus. The Company is developing an oral formulation of difelikefalin, a selective, peripherally acting, non-scheduled kappa opioid receptor agonist, for the treatment of chronic pruritus associated with notalgia paresthetica (NP), a common, underdiagnosed neuropathy affecting the upper back for which there are no FDA-approved therapies. The Company is conducting a Phase 2/3 clinical program in NP with topline results of the dose-finding portion expected in the third quarter of 2024. Cara Therapeutics also developed an IV formulation of difelikefalin, which is approved in the United States, EU, and multiple other countries for the treatment of moderate-to-severe pruritus associated with advanced chronic kidney disease in adults undergoing hemodialysis. The IV formulation is out-licensed worldwide.

Cara Therapeutics Global Highlights

Location
Employees

North America
132

Minus sign iconPlus sign icon
  • United States Of America
    130
  • Canada
    2

Europe
1

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    1

South America
1

Minus sign iconPlus sign icon
  • Brazil
    1

Cara Therapeutics's Leadership

Contact profiles from Cara Therapeutics

Name
Title
Contact Info
Location
Last Update

Frequently Asked Questions

What is Cara Therapeutics known for?

Minus sign iconPlus sign icon
Cara Therapeutics was founded in 2004 operates in the Biotechnology Research industry. The company's main headquarters is located in 400 Atlantic St Suite 500 Stamford, Connecticut 06901 US; you can contact the main corporate office by phone at +1-203-567-1500. Explore Cara Therapeutics's company overview page for more information.

What is Cara Therapeutics's most common email format?

Minus sign iconPlus sign icon
Cara Therapeutics employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Cara Therapeutics email formats with LeadIQ.

How many employees does Cara Therapeutics have currently?

Minus sign iconPlus sign icon
Cara Therapeutics has approximately 73 employees as of June 2024. These team members are located across 3 continents, including North AmericaEuropeSouth America.

Who are Cara Therapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of June 2024, Cara Therapeutics's key employees include:

  • Chief Strategy Officer & Head Of Investor Relations: I. F.
  • Chief Financial Officer: R. M.
  • Chief Medical Officer: J. S.
  • Chief Medical Officer: J. G.
  • Chief Medical Officer: J. G.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.